Livre Blanc
Pharma's Frozen Assets
Cold chain medicines
Jan 27, 2023
Download

Healthcare is contributing an estimated 4.2% of the global carbon footprint. The share of pharmaceuticals is significant.

Refrigerated or frozen medicines have an even more energy-intensive lifecycle from manufacturing until they reach the patients. However, the information on which medicines require a temperature-controlled environment is not easy to come by.

In this paper, we define the cold chain market using a combination of public and IQVIA data and give a perspective on key developments.

Related solutions

Contact Us